Quotes from Liz Parrish

We are using both visual biomarkers, MRI and a panel of blood and tissue testing including work on telomere length with Spectracell and Life Length and epigenetic testing.

I would suggest always getting behind a company that shares your goals, whom you have access to the people who run it and who truly care about the world. This way we steer the ship together and many fears can be let go of.

We are a company for the people, please get involved. Be part of the conversation.

BioViva is trying to help improve human health and wellbeing, and alleviate suffering. We are not trying to determine who should live or die. Everyone has a right to life without suffering.

We will 'de-age' progressively, as cures are developed.

Yes, we are looking into gene therapies for immune cells to target senescent cells.

I have aging as a disease.

The gene therapies on my body are to measure the effects on humans. There is plenty of animal research to support these gene therapies but no one was conducting human tests.

But do remember that the most important risk factor for cancer is growing older. Most cancers occur in people over the age of 65.

I think gene therapy and nanotechnology go hand in hand.

I hope that the image of gene therapy is changing. It seems to be.

Hundreds of people are undergoing gene therapy today. There are no known neurological issues.

Gene therapy technology is much like computing technology. We had to build the super computer which cost $8 million in 1960. Now everyone has technologies that work predictably and at a cost the average person can afford.

Crisper is great. The future of gene therapy looks bright.

I was awake for the therapy, it was documented by a film crew. I am proud to have taken part of helping millions of people even if it has bad results.

Our goal is to build laboratories that will have the mission of a cGMP product at a reduced cost.

Currently, we are working to deliver our anti-aging gene therapies to terminally ill people for compassionate care. Although, in the future we think that preventative medicine against aging would begin at a much younger age.

Work by Maria Blasco, Calvin Harley, Michael Fossel, Woodring Wright and Shay and Ronald Depinho in particular are of interest but there are literally thousands of articles relating to telomerase, telomeres and the biology behind it.

Aging is one of the most visual diseases on the planet and includes things that we all know like wrinkles and grey hair, but also brain atrophy, muscle wasting and organ damage.

I agree Maria Blasco has achieved amazing things with telomerase induction and we are hopeful this will translate to the human model.

We can not control the aging reversal to a specific year today, that will come in the future. It is hypothesized that you will not reverse in physical appearance to less than a young adult. We see this in mice as well.

The biotech game is quickly changing. The people must demand their use of these treatments.

You have little to no response to AAV the first time your body sees it. If you used the same vector twice you would want to bump up immunosuppression. I believe there will be many new ways to deliver genes in the future as well.

Epigenetics is very important. We are keeping a close eye on iPS cells and other genetic methods of reprogramming the epigenome.